Research

Novel engineered vectors (recombinant adeno-associated virus [vAAV]) may provide efficient targeting for photoreceptors avoiding risks of collateral damage.

Researchers at the Department of Ophthalmology, Ludwig-Maximilians-University, Munich, have reported results on novel engineered viral vectors aimed to efficiently target photoreceptors.  The research used a… Read More »Novel engineered vectors (recombinant adeno-associated virus [vAAV]) may provide efficient targeting for photoreceptors avoiding risks of collateral damage.

Surgical “pearls” point to valuable observations among 120 treatments using subretinal gene therapy for inherited retinal degenerations.   

Surgical “pearls” of research have been published in the journal, Retina (accessed January 18, 2021), following the completion of 120 subretinal surgeries, performed by a… Read More »Surgical “pearls” point to valuable observations among 120 treatments using subretinal gene therapy for inherited retinal degenerations.